The role of argyrophilic nucleolar organizing region-associated proteins in clinical exacerbation of chronic obstructive pulmonary disease
dc.contributor.author | Sönmez, Feruza Turan | |
dc.contributor.author | Eröz, Recep | |
dc.date.accessioned | 2020-04-30T23:34:25Z | |
dc.date.available | 2020-04-30T23:34:25Z | |
dc.date.issued | 2018 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | TURAN SONMEZ, Feruza/0000-0001-8817-8521 | en_US |
dc.description | WOS: 000453601300014 | en_US |
dc.description | PubMed: 30088791 | en_US |
dc.description.abstract | Objective To investigate whether argyrophilic nucleolar organizing region-associated protein (AgNOR) parameters can be used as a biomarker that could potentially help with the management and clinical prognosis of chronic obstructive pulmonary disease (COPD) exacerbation. Methods This case-control study enrolled patients with COPD who were admitted to the Emergency Department and healthy sex- and age-matched control subjects. Peripheral blood samples were collected at hospital admission and the peripheral lymphocytes were silver-stained to investigate the quantity and distribution of AgNOR proteins. Fifty nuclei per patient were viewed and the total AgNOR area/total nuclear area (TAA/TNA) ratio and the mean AgNOR number for each patient were calculated. Results A total of 20 patients with COPD exacerbation and 17 healthy control subjects were recruited to the study. The TAA/TNA ratio and the mean AgNOR number were significantly higher in the patients with COPD exacerbation compared with the healthy control subjects. The mean AgNOR number showed a positive correlation with the pCO(2) levels on admission. Conclusion AgNOR protein levels were elevated during a COPD exacerbation compared with healthy control subjects and there was a positive correlation between pCO(2) levels and mean AgNOR number. | en_US |
dc.identifier.doi | 10.1177/0300060518788751 | en_US |
dc.identifier.endpage | 5003 | en_US |
dc.identifier.issn | 0300-0605 | |
dc.identifier.issn | 1473-2300 | |
dc.identifier.issue | 12 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 4995 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0300060518788751 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/5161 | |
dc.identifier.volume | 46 | en_US |
dc.identifier.wos | WOS:000453601300014 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.relation.ispartof | Journal Of International Medical Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Chronic obstructive pulmonary disease | en_US |
dc.subject | argyrophilic nucleolar organizing region-associated proteins | en_US |
dc.subject | exacerbation | en_US |
dc.subject | management | en_US |
dc.subject | marker | en_US |
dc.title | The role of argyrophilic nucleolar organizing region-associated proteins in clinical exacerbation of chronic obstructive pulmonary disease | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 5161.pdf
- Boyut:
- 385.02 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text